Sabine D. Brookman-May, Senior Vice President and Therapeutic Area Head of Urologic Oncology at Aura Biosciences, shared a post on X:
“What is the best strategy in BCG unresponsive HR NMIBC?
Carme Mir: one line salvage treatment + consider also initial response to BCG
Ashish M. Kamat: improved cysto + imaging + biomarkers are needed.”
